Akero Therapeutics, Inc. Temporary Equity, Liquidation Preference
Akero Therapeutics, Inc. had Temporary Equity, Liquidation Preference of $96.36 million as of 2018-12-31, per its 10-K filed 2020-03-16.
Discontinued › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2020-03-16
- 2018-12-31: Temporary Equity, Liquidation Preference $96.36M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2018-12-31 | $96.36M 10-K · filed 2020-03-16 |